Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection

Liver Transplantation

Volumn 16, Issue 4, 2010, Pages 536-537

  Audimoolam, Vinod K ^a   Foxton, Mathew R ^b   Agarwal, Kosh ^a   O'Grady, John G ^a   Heneghan, Michael A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

DIABETES MELLITUS; GRAFT SURVIVAL; HEPATITIS C; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; RNA VIRUS; VIRUS LOAD; COHORT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE COURSE; HEPACIVIRUS; LIVER; LIVER FAILURE; METABOLISM; PROCEDURES; TREATMENT OUTCOME; VIROLOGY;

COHORT STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77950683840     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22015     Document Type: Letter

References (12)

1. Shackel NA, Jamias J, Rahman W, Prakoso E, Strasser SI, Koorey DJ, et al. Early high peak hepatitis C viral load levels independently predict hepatitis C-related liver failure post-liver transplantation. Liver Transpl 2009;15:709-718.
2. Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000;32:852-858.
3. Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant. Liver Transpl 2009; 15:592-599.
4. Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, et al. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study. Liver Transpl 2007;13: 733-740.
5. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;24:1135-1139.
6. Bigam DL, Pennington JJ, Carpentier A, Wanless IR, Hemming AW, Croxford R, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000;32:87-90.
7. Foxton MR, Quaglia A, Muiesan P, Heneghan MA, Portmann B, Norris S, et al. The impact of diabetes mellitus on fibrosis progression in patients transplanted for hepatitis C. Am J Transplant 2006;6:1922-1929.
8. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003;125:1695-1704.
9. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000;75:355-359.
10. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific over expression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A 2001;98:7522-7527.
11. Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 1999;29:1743-1751.
12. Burra P, Loreno M, Russo FP, Germani G, Galligioni A, Senzolo M, et al. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl 2009;15:619-628.